Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression.

Dunn RT, Kimbrell TA, Ketter TA, Frye MA, Willis MW, Luckenbaugh DA, Post RM.

Biol Psychiatry. 2002 Mar 1;51(5):387-99.

PMID:
11904133
2.

Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls.

Dunn RT, Willis MW, Benson BE, Repella JD, Kimbrell TA, Ketter TA, Speer AM, Osuch EA, Post RM.

Psychiatry Res. 2005 Nov 30;140(2):181-98.

PMID:
16257515
3.

Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients--a preliminary PET study.

Kumano H, Ida I, Oshima A, Takahashi K, Yuuki N, Amanuma M, Oriuchi N, Endo K, Matsuda H, Mikuni M.

J Psychiatr Res. 2007 Oct;41(7):591-9. Epub 2006 May 8.

PMID:
16684544
4.

Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: the role of PET and SPECT studies.

Gonul AS, Coburn K, Kula M.

Int Rev Psychiatry. 2009;21(4):323-35. doi: 10.1080/09540260902962131. Review.

PMID:
20374147
5.
6.

Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography.

al-Mousawi AH, Evans N, Ebmeier KP, Roeda D, Chaloner F, Ashcroft GW.

Br J Psychiatry. 1996 Oct;169(4):509-16.

PMID:
8894204
7.

Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states.

Hosokawa T, Momose T, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):243-50. doi: 10.1016/j.pnpbp.2008.11.014. Epub 2008 Dec 3.

PMID:
19100808
8.

Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.

Brooks JO 3rd, Wang PW, Bonner JC, Rosen AC, Hoblyn JC, Hill SJ, Ketter TA.

J Psychiatr Res. 2009 Jan;43(3):181-8. doi: 10.1016/j.jpsychires.2008.04.015. Epub 2008 Jun 25.

9.

Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.

Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H.

Arch Gen Psychiatry. 2004 Jan;61(1):34-41.

PMID:
14706942
10.

Relationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping.

Périco CA, Skaf CR, Yamada A, Duran F, Buchpiguel CA, Castro CC, Soares JC, Busatto GF.

Neurosci Lett. 2005 Aug 26;384(3):265-70.

PMID:
15921853
11.

[Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].

Dumas R, Boyer L, Richieri R, Guedj E, Auquier P, Lançon C.

Encephale. 2014 Feb;40(1):74-80. doi: 10.1016/j.encep.2013.04.004. Epub 2013 Oct 1. French.

PMID:
24091070
12.

Regional cerebral glucose metabolism in major depressive disorder.

Hurwitz TA, Clark C, Murphy E, Klonoff H, Martin WR, Pate BD.

Can J Psychiatry. 1990 Nov;35(8):684-8.

PMID:
2282619
13.

Frontal and parietal metabolic disturbances in unipolar depression.

Biver F, Goldman S, Delvenne V, Luxen A, De Maertelaer V, Hubain P, Mendlewicz J, Lotstra F.

Biol Psychiatry. 1994 Sep 15;36(6):381-8.

PMID:
7803599
14.

Changes in regional cerebral blood flow demonstrated by single photon emission computed tomography in depressive disorders: comparison of unipolar vs. bipolar subtypes.

Tutus A, Simsek A, Sofuoglu S, Nardali M, Kugu N, Karaaslan F, Gönül AS.

Psychiatry Res. 1998 Sep 28;83(3):169-77.

PMID:
9849726
15.

Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.

Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2002 Feb 1;51(3):237-52.

PMID:
11839367
16.

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W.

Arch Gen Psychiatry. 2004 Jan;61(1):73-84.

PMID:
14706946
17.

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR Jr.

Arch Gen Psychiatry. 2002 Mar;59(3):250-61.

PMID:
11879163
18.

Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients.

Osuch EA, Ketter TA, Kimbrell TA, George MS, Benson BE, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2000 Nov 15;48(10):1020-3.

PMID:
11082477
19.

Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: effects of levothyroxine.

Bauer M, Berman SM, Schlagenhauf F, Voytek B, Rasgon N, Mandelkern MA, Whybrow PC, London ED.

Psychiatry Res. 2010 Jan 30;181(1):71-6. doi: 10.1016/j.pscychresns.2009.07.001.

PMID:
19962861
20.

Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy.

McCormick LM, Boles Ponto LL, Pierson RK, Johnson HJ, Magnotta V, Brumm MC.

J ECT. 2007 Dec;23(4):265-73.

PMID:
18090701

Supplemental Content

Support Center